Water Vapor Ablation for Prostate Cancer: Long-Term Registry
Recruiting · NCT07455058 · Observational (researchers observe without assigning treatment)
View the official record on ClinicalTrials.gov →Interventions studied
Vanquish Therapy
What this trial is about
The purpose of the registry is to evaluate real-world safety, efficacy, and patient reported outcomes among participants receiving Vanquish Water Vapor Ablation System therapy (Vanquish Therapy). This includes longitudinal assessment of patients who have received or will receive the therapy one or multiple times as part of routine clinical care and encompasses those who completed a company-sponsored Vanquish therapy study (as applicable).
Who can take part
Age range
No age limits stated
Sex
Male
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Candidate for Vanquish therapy per physician discretion or participant has completed a company-sponsored Vanquish therapy study.
- Participant is willing and able to provide written informed consent.
Exclusion criteria
- Contraindications per the Vanquish IFU
- Previously participated in VAPOR 2 study and is not planning to receive further Vanquish therapy.
Where it is running
4 locations listed across 4 US states.
- WK Advanced Urology Specialists - Bossier City, Louisiana, United States
- Minnesota Urology - Woodbury, Minnesota, United States
- The Urology Place, Inc. - San Antonio, Texas, United States
- Urology of Virginia - Virginia Beach, Virginia, United States